Dr Paul Eliadis AM was recently involved in a global Phase III study investigating Ibrutinub and Venetoclax for the treatment of patients with relapsed/refractory mantle cell lymphoma. You can read the full study and results by clicking here.
On the study, Dr Eliadis AM noted:
“It is always a privilege to work alongside my colleagues across the globe to help improve treatment approaches for patients with haematological conditions. I recently had the pleasure of contributing to an international multi-institutional Phase III study investigating Ibrutinub and Venetoclax for the treatment of patients with relapsed/refractory mantle cell lymphoma.”
Dr Paul Eliadis AM in Medicine
Dr Paul Eliadis practices at Icon Cancer Care with clinics situated throughout Queensland. Dr Eliadis has been and continues to be involved in numerous clinical trials in relation to malignant disease both as principal investigator and sub-investigator. He held the position of Chairman of the HOCA Board (now known as Icon Cancer Care) from 2006 to 2009.
In the specialties of Clinical Haematology and Medical Oncology, Dr Eliadis lists his particular interests as the management of malignant disease and stem cell transplantation. These include malignant Lymphoma, Hodgkin’s Disease, acute and chronic Leukaemias, colorectal cancers, other malignancies of the gastro-intestinal tract, breast cancer, lung cancer, sarcomas, prostate cancer, malignant tumors of the central nervous system and malignancies of the genito-urinary tract. Dr Paul Eliadis works closely with Radiation Oncologists in managing patients with malignant disease who require concurrent chemo-radiotherapy. These include patients with cancer of the head and neck, oesophagus and rectum.
More About Dr Paul Eliadis AM
With over 35 years experience in Clinical Haematology and Oncology,
Dr Paul Eliadis is at the peak of his career. As a founder of Haematology and Oncology Clinics of Australia (HOCA), Dr Eliadis has and continues to support medical research that explores promising opportunities in cancer care.
The devotion to his profession extends from Medicine to an appreciation for the arts, ancient history and the classics. More recently, his support through a generous donation to the University of Queensland, has led to the creation of the Chair of Ancient History and the Classics within the newly named School for Historical and Philosophical Inquiry.
Stay Updated With Dr Paul Eliadis AM
Want to stay updated on the latest news and thoughts from Dr Paul Eliadis AM and his work in Clinical Haematology and Oncology? You can click here to follow Dr Paul Eliadis AM on LinkedIn. Dr Paul Eliadis’ official site here is also a great place to stay updated on the latest news on Dr Paul Eliadis AM.